Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

242
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
242
Determination of Renal Drug Clearance: Graphical and Midpoint Methods01:07

Determination of Renal Drug Clearance: Graphical and Midpoint Methods

190
Renal clearance, a crucial parameter in pharmacokinetics, can be determined using two different methods: the graphical method and the midpoint method. These methods provide insights into the rate of drug excretion by the kidneys and aid in assessing renal function.
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
190
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

362
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
362
One-Compartment Open Model: Urinary Excretion Data and Determination of k01:11

One-Compartment Open Model: Urinary Excretion Data and Determination of k

260
The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also...
260
Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

299
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
299
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

162
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
162

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Association between Cerebral Oxygenation and CKD in Older Adults.

Kidney360·2026
Same author

Interpretability of Home Blood Pressure Measurements in Haemodialysis A Post Hoc Analysis of a Randomised Cross-Over Study.

Nephrology (Carlton, Vic.)·2025
Same author

Multimodal Artificial Intelligence in Medicine.

Kidney360·2024
Same author

Artificial intelligence and digital health for volume maintenance in hemodialysis patients.

Hemodialysis international. International Symposium on Home Hemodialysis·2022
Same author

Protocol of a pilot-scale, single-arm, observational study to assess the utility and acceptability of a wearable hydration monitor in haemodialysis patients.

Pilot and feasibility studies·2022

Related Experiment Video

Updated: Aug 27, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

792

Learning Methodological Lessons from Exemplar Studies in Nephrology: PEXIVAS and Sample Size Calculation.

Vicki Sandys1, Donal J Sexton2,3

  • 1Royal College of Surgeons in Ireland, Dublin, Ireland.

Kidney360
|September 30, 2022
PubMed
Summary

Accurate sample size calculations are crucial for study power. Adjusting for factors like effect size and event rates ensures reliable results, with strategies to maintain power if event rates are lower than expected.

Keywords:
PEXIVASclinical nephrologyplasma exchangeplasmapheresissample size

More Related Videos

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

290
A Modified Precipitation Method to Isolate Urinary Exosomes
05:05

A Modified Precipitation Method to Isolate Urinary Exosomes

Published on: January 16, 2015

17.7K

Related Experiment Videos

Last Updated: Aug 27, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

792
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

290
A Modified Precipitation Method to Isolate Urinary Exosomes
05:05

A Modified Precipitation Method to Isolate Urinary Exosomes

Published on: January 16, 2015

17.7K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Epidemiology

Background:

  • Sample size calculations are essential for determining study power.
  • Estimating required sample size relies on pre-trial literature and chosen effect sizes.
  • Clinically relevant treatment effect sizes directly influence sample size requirements.

Purpose of the Study:

  • To outline the fundamental principles of sample size calculations in research.
  • To discuss factors influencing study power, including effect size and event rates.
  • To present strategies for maintaining study power when event rates are lower than anticipated.

Main Methods:

  • Review of statistical principles for sample size estimation.
  • Discussion of effect size and its impact on required sample size.
  • Exploration of time-to-event study designs to manage censoring and competing risks.

Main Results:

  • Smaller effect sizes necessitate larger sample sizes or higher event rates for statistical significance.
  • Lower-than-expected event rates can diminish study power due to various factors.
  • Time-to-event designs inherently account for censoring and competing risks.

Conclusions:

  • Effective sample size calculation is vital for robust study outcomes.
  • Strategies such as increasing sample size or study duration can mitigate risks of low event rates.
  • Careful consideration of these factors enhances the reliability and validity of research findings.